about
Tegaserod for the treatment of irritable bowel syndrome and chronic constipationTegaserod for the treatment of irritable bowel syndromeIntestinal microbiota in functional bowel disorders: a Rome foundation reportImmunoglobulin E in irritable bowel syndrome: another target for treatment? A case report and literature reviewReview article: the history of hypnotherapy and its role in the irritable bowel syndromeSynesthesia, pseudo-synesthesia, and irritable bowel syndrome.The Manchester Color Wheel: validation in secondary school pupils.Relationship of abdominal bloating to distention in irritable bowel syndrome and effect of bowel habit.The Intestinal Gas Questionnaire: development of a new instrument for measuring gas-related symptoms and their impact on daily life.Acupuncture for irritable bowel syndrome: a protocol for a pragmatic randomised controlled trial.The Manchester Color Wheel: development of a novel way of identifying color choice and its validation in healthy, anxious and depressed individuals.Mood color choice helps to predict response to hypnotherapy in patients with irritable bowel syndromeAntibodies to Campylobacter pyloridis in household contacts of infected patients.Severe sexual dysfunction in women with the irritable bowel syndrome: comparison with inflammatory bowel disease and duodenal ulcerationA randomised controlled trial on hypnotherapy for irritable bowel syndrome: design and methodological challenges (the IMAGINE study).Changes of the human gut microbiome induced by a fermented milk productIrritable bowel syndrome: diagnosis and management.Changes in rectal sensitivity after hypnotherapy in patients with irritable bowel syndrome.Abdominal distension in female patients with irritable bowel syndrome: exploration of possible mechanisms.The challenge of developing new therapies for irritable bowel syndromeDo probiotics improve symptoms in patients with irritable bowel syndrome?Avoiding analgesic escalation and excessive healthcare utilization in severe irritable bowel syndrome: a role for intramuscular anticholinergics?Acupuncture for irritable bowel syndrome: primary care based pragmatic randomised controlled trial.'Nodular necrobiosis': a new cutaneous manifestation of Crohn's disease?Symptoms of irritable bowel syndrome in ulcerative colitis in remissionGuidelines on the irritable bowel syndrome: mechanisms and practical management.Oesophageal motility in the irritable bowel syndrome.First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome.The rectum: a window to irritable bowel syndrome?An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries.Irritable bowel syndrome: the problem and the problem of treating it - is there a role for probiotics?The LUCK study: Laxative Usage in patients with GP-diagnosed Constipation in the UK, within the general population and in pregnancy. An epidemiological study using the General Practice Research Database (GPRD).Ambulatory abdominal inductance plethysmography: towards objective assessment of abdominal distension in irritable bowel syndrome.Infection and irritability.Benefit-risk assessment of tegaserod in irritable bowel syndrome.Treatment of non-cardiac chest pain: a controlled trial of hypnotherapy.Unexpected consequences: women's experiences of a self-hypnosis intervention to help with pain relief during labour.Quality of life and illness costs in irritable bowel syndrome.Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.Faecal incontinence-the hidden scourge of irritable bowel syndrome: a cross-sectional study.
P50
Q24242922-C3EA0E15-427E-4A98-B601-E5C87BF72D55Q24247426-4978B7B8-91B6-46B1-8B64-0142E3CF1F6FQ24631357-0018FC4C-DA63-4AE7-8C5C-3D4BE96B9FB4Q26795564-576B9952-6683-4D27-800F-CBB6CCF96E43Q28315284-D71E2671-753E-405F-84A7-F3D0758BBE31Q30412350-5E9150C1-F2A6-4F16-8DBF-ADBC5B82F9E7Q30420983-0AA65B7C-0425-4FFB-9054-B1D767EB17FAQ33436052-DFF48953-AECA-4058-B9D0-2082249AA67FQ33464699-AB3C249E-D2EC-452D-8EC6-A7376312129BQ33610964-77995DE7-1986-4DEF-8DAA-C485D2EE46ADQ33692364-5E97DF0F-CE37-4D5B-9CCD-FF36C88CBAA0Q33765147-24F318C3-4AC0-4FF3-B203-FDC841F22977Q34069044-50F107A4-183E-4FFB-98B9-0A6F04D0E39EQ34073926-D65988E3-55D0-41D0-9AA3-98D12800FAD5Q34106923-B965E3A7-5E07-4485-B252-BFC9AB2505E3Q34162526-C084E767-C6E9-4181-841B-A937358D08DEQ34334525-ADC0A7E6-FADD-400F-8D78-39DFC45BDFE4Q34392722-2541AA1A-2AAF-4C1E-A31F-938D283C1CFFQ34393760-0E1090D3-3EDE-4223-8C50-1EABA036C816Q34408997-4833D784-0B94-4BE3-97FE-26BB7E9DB0F5Q34409031-2B3B4E6B-049B-4817-A28C-FE7E771E4662Q34418745-2F132DB7-37A8-416B-A866-F680ADDC364EQ34457042-80FEC4F9-EA8A-484E-9407-6BFFA0E1B582Q34493387-9609DA3B-B52F-4F01-82E7-74F4414B6F6BQ34495732-293AE886-5966-4461-9C96-4F05D9664216Q34626602-E587BD58-4860-4D80-800E-4D262D36F2C7Q34778716-365C5DFF-8885-4D4F-A98D-5FB0DF9DFC85Q34794063-FD45E338-6A05-4948-99D2-F43BF9657A84Q34869497-2FE0AFBE-3283-4ABA-BE25-DF66911DD70AQ35044207-2A46904D-9454-43C0-AC52-CA0D0742A4B5Q35231621-3ADB5178-C8C3-4E5F-8253-275669BF992AQ35276684-095D072A-2A63-472A-8B09-98097719F163Q35362718-36ACF4F9-D0C9-4953-8609-25CADDB24039Q35594976-80A6A106-5D15-45C9-A8D5-9967972EBEF5Q35683216-677FA36F-37B8-416D-A109-724307AD4F44Q35760880-A43B9F72-FB7F-4D33-902A-9B5ADA528E7BQ35789029-0F819F5B-FFBA-4CEB-AD21-5E9DF21041BBQ35838021-7E26D8B5-05C9-4DB5-B1BD-0304B5690F05Q35841225-41862777-4E79-41AE-991D-35134457BA26Q35943352-9631DF3C-249B-45BA-8437-A8936302110F
P50
description
gastroenteroloog
@nl
researcher
@en
researcher
@en-gb
ricercatore
@it
հետազոտող
@hy
name
Peter J Whorwell
@ast
Peter J Whorwell
@en
Peter J Whorwell
@en-gb
Peter J Whorwell
@es
Peter J Whorwell
@nl
Peter J Whorwell
@sl
type
label
Peter J Whorwell
@ast
Peter J Whorwell
@en
Peter J Whorwell
@en-gb
Peter J Whorwell
@es
Peter J Whorwell
@nl
Peter J Whorwell
@sl
altLabel
Peter Whorwell
@en
prefLabel
Peter J Whorwell
@ast
Peter J Whorwell
@en
Peter J Whorwell
@en-gb
Peter J Whorwell
@es
Peter J Whorwell
@nl
Peter J Whorwell
@sl
P1006
P214
P227
P1006
P1153
35243963700
P21
P213
0000 0001 2436 1060
P214
P227
1124562117
P31
P496
0000-0002-5220-8474
P735
P7859
lccn-nb2018001919